港股异动 | 微创医疗(00853)涨超4% 花旗料公司25年下半年将录得盈利此前战略合并将成为上行潜力

智通财经01-14

智通财经APP获悉，微创医疗(00853)涨超4%，截至发稿，涨4.34%，报12.27港元，成交额7953.15万港元。消息面上，微创医疗此前发布公告，微创心通的独立股东已于2025年12月15日举行的微创心通股东特别大会上批准合并协议及其项下拟进行的交易。预期合并将于2025年12月19日或前后完成，公告称，本次战略合并是本公司优化资源配置、提升整体竞争力的关键举措，旨在全面强化双方在结构性...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2603575326?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-14 09:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603575326","market":"sh","top_or_hot":-1,"title":"港股异动 | 微创医疗(00853)涨超4% 花旗料公司25年下半年将录得盈利 此前战略合并将成为上行潜力","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，微创医疗(00853)涨超4%，截至发稿，涨4.34%，报12.27港元，成交额7953.15万港元。消息面上，微创医疗此前发布公告，微创心通的独立股东已于2025年12月15日举行的微创心通股东特别大会上批准合并协议及其项下拟进行的交易。预期合并将于2025年12月19日或前后完成，公告称，本次战略合并是本公司优化资源配置、提升整体竞争力的关键举措，旨在全面强化双方在结构性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1392560.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 微创医疗(00853)涨超4% 花旗料公司25年下半年将录得盈利 此前战略合并将成为上行潜力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 微创医疗(00853)涨超4% 花旗料公司25年下半年将录得盈利 此前战略合并将成为上行潜力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-14 09:51 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1392560.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，微创医疗(00853)涨超4%，截至发稿，涨4.34%，报12.27港元，成交额7953.15万港元。消息面上，微创医疗此前发布公告，微创心通的独立股东已于2025年12月15日举行的微创心通股东特别大会上批准合并协议及其项下拟进行的交易。预期合并将于2025年12月19日或前后完成，公告称，本次战略合并是本公司优化资源配置、提升整体竞争力的关键举措，旨在全面强化双方在结构性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1392560.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0098860793.USD","symbol_name":"FRANKLIN INCOME \"A\" INC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1392560.html","article_id":"2603575326","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603575326","pubTimestamp":1768355516,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，微创医疗涨超4%，截至发稿，涨4.34%，报12.27港元，成交额7953.15万港元。消息面上，微创医疗此前发布公告，微创心通的独立股东已于2025年12月15日举行的微创心通股东特别大会上批准合并协议及其项下拟进行的交易。花旗指出，微创医疗基本面持续改善，公司2025年上半年，净亏损按年收窄66%，该行预计公司将在2025年下半年录得盈利。公司亦获得合并后的协同效应，将成为公司的上行潜力。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","00853":"微创医疗","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","BK1583":"高瓴概念","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","BK4566":"资本集团","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","LU0106831901.USD":"贝莱德世界金融基金A2","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","BK4504":"桥水持仓","BK4559":"巴菲特持仓","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","BK1589":"北水核心资产","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","BK4588":"碎股","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK1585":"昨日强势股","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","LU2125154935.USD":"ALLSPRING (LUX) WF GLOBAL EQUITY ENHANCED INCOME \"I\" (USD) INC","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","BK4207":"综合性银行","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD"},"translate_title":"Changes in Hong Kong stocks | MicroPort Medical (00853) rose more than 4%. Citigroup expects the company to record profits in the second half of 25 years. Previous strategic mergers will become upside potential","themeId":"19a45d98d676f675f3dd1dad1f11fa69","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00853":1.5},"content_text":"智通财经APP获悉，微创医疗(00853)涨超4%，截至发稿，涨4.34%，报12.27港元，成交额7953.15万港元。消息面上，微创医疗此前发布公告，微创心通的独立股东已于2025年12月15日举行的微创心通股东特别大会上批准合并协议及其项下拟进行的交易。预期合并将于2025年12月19日或前后完成，公告称，本次战略合并是本公司优化资源配置、提升整体竞争力的关键举措，旨在全面强化双方在结构性心脏病及心律管理领域的协同效应。花旗指出，微创医疗基本面持续改善，公司2025年上半年，净亏损按年收窄66%，该行预计公司将在2025年下半年录得盈利。另外，该行预期高增长的海外平台将在2025年按年实现70%至80%，且增长趋势或在2026年持续。公司亦获得合并后的协同效应，将成为公司的上行潜力。光大证券认为，综合考虑集采影响、公司降低各项费用、聚焦核心业务等因素，预计微创医疗有望实现持续减亏，上调25-26年净利润预测为-30/96百万美元(原值为-59/91百万美元)。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603575326","isCrawlerRequest":true}

港股异动 | 微创医疗(00853)涨超4% 花旗料公司25年下半年将录得盈利 此前战略合并将成为上行潜力

精彩评论

港股异动 | 微创医疗(00853)涨超4% 花旗料公司25年下半年将录得盈利此前战略合并将成为上行潜力